|
[1] J. L. Larmarsh and A. J. Baratta, Introduction to Nuclear Engineeinrg, 3rd edition (Prentice Hall, 2001).
[2] G. F. Knoll, Radiation detection and measurement, 3rd edition (John Wiley & Sons, Inc., New York, 2000).
[3] Neutron Capture Therapy: Principle and Applications, edited by W.A.G. Sauerwein , A. Wittig , R. Moss, Y. Nakagawa, (Springer, Heidelberg, 2012).
[4] F. H. Attix, Introduction to Radiological Physics and Radiation Dosimetry, (John Wiley & Sons, Inc., New York, 1986).
[5] R. Serber, “Nuclear Reactions at High Energies,” Physical Review, 72:1114–1115, (1947).
[6] K. C. Gwosch, Non-Invasive Monitoring of Carbon Ion Beam Therapy by Tracking of Secondary Ions – An Initial Study. Diploma thesis, University of Heidelberg, (2012).
[7] E. Pedroni et al., “Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams. Phys. in Med. Biol., 50:541–561, (2005).
[8] “Stopping powers and ranges for electrons and positrons” Technical Report 37, (International Commission on Radiation Units and Measurements, 1984).
[9] “Stopping powers and ranges for protons and alpha particles” Technical Report 49, (International Commission on Radiation Units and Measurements, 1993).
[10] “Stopping of ions than helium” Technical Report 73, (International Commission on Radiation Units and Measurements, 2005).
[11] P. V. Valivov, “Ionization losses of high-energy heavy particles,” Soviet Physics Jetp User, 5(4), 749-751, (1957).
[12] H. A. Bethe, “Molière’s theory of multiple scattering,” Phys. Rev., 89(6), 1256-1266, (1953).
[13] H. Paganetti et al., “Relative biological effectiveness (RBE) values for proton beam therapy,” Int. J. Radiat. Oncol. Biol. Phys., 53(2) 407-421, (2002).
[14] E. Fokas et al., “Ion beam radiobilogy and cancer: time to update ourselves,” Biochimita et Biophysica Acta, 1796(2), 216-229, (2009).
[15] J. Chadwick, “the existence of a neutron,” Proc. R. Soc. London A 136, 692-708, (1932).
[16] H. J. Taylor and M. Goldhaber, “Detection of nuclear disintegration in a photographic emulsion,” Nature, 135, 341-348, (1935).
[17] G. L. Locher, “Biological effects and therapeutic possibilities of neutrons,” Am J Roentgenol Radium Ther, 36(1), 1-13, (1936).
[18] L. E. Farr et al., “Neutron capture therapy of gliomas using boron-10,” Trans. Am. Neurol. Assoc., 79, 110-113, (1954).
[19] J. O. Archambeau, “The effect of increasing exposures of the 10B(n,α)7Li reaction on the skin of man. Radiology, 94, 178-187, (1970).
[20] D. N. Slatkin, “A history of boron neutron capture therapy of brain tumors,” Brain, 114, 1609-1629, (1991).
[21] W. H. Sweet, A. H. Soloway, G. L. Brownell, “Boron-slow neutron capture therapy of gliomas,” Acta Radiol. Stockholm, 1, 114-121, (1963).
[22] A. K. Asbury, R. G. Ojeman, S. L. Nielsen, W. H. Sweet, “Neuropathological study of gourteen xases of malignant brain tumor treated by boron-10 slow neutron capture radiation,” J. Neuropathol. Exp. Neurol., 31(2), 278-303, (1972).
[23] R. Moss, “Critical review, with an optimistic outlook, on boron neutron capture therapy,” App. Radiat. Isot., (available URL: http://dx.doi.org/10.1016/j.apradiso.2013.11.109) (2013).
[24] A. H. Sloway, H. Hatanaka, M. A. Davis, “Penetration of brain and brain tumor VII tumor binding sulfhydryl boron compounds. J. Med. Chem., 10, 714-717, (1697).
[25] H. Hanataka, Boron-neutron capture therapy for tumors (Nishimura Co., Niigata, 1986).
[26] H. Hanataka, “Clinical results of boron neutron capture therapy,” Basic Life Sci., 54, 15- 21, (1990).
[27] H. Hanataka, W. H. Sweet, K. Sano, F. Ellis, “The present status of boron neutron capture therapy for tumors,” Pure Appl. Chem., 63(3), 373-374, (1991).
[28] Y. Mishima et al., “First human clinical trial of melanoma neutron capture diagnosis and therapy,” Strahlenther Onkol., 165(2-3), 251-254, (1989).
[29] R. Wilson, “Radiological use of fast protons,” Radiology, 47, 487-491, (1946).
[30] O. Jäkel, Personal communication, (2014).
[31] J. R. Castro, “Clinical Programs: a review of past and existing hadron protocols,” in Amaldi. U, Larrson B, Lemoigne Advances in Hadrontherapy, (Elsevier Science, Amsterdam, 1997).
[32] J. R. Castro et al., “Experience in charged particle irradiation of tumors of the skull base 1977-1992,” Int. J. Radiat. Oncol. Biol. Phys., 29, 647-655, (1994).
[33] Particle Therapy Co-Operative Group (available URL: http://www.ptcog.ch/) accessed in March 2014.
[34] W. P. Voorbraak et al., Recommendation for the dosimetry of boron neutron capture therapy (BNCT), (The JRC, Petten, the Netherlands, 2003).
[35] “Neutron dosimetry for medicine and biology,” Technical Report 26, (International Commission on Radiation Units and Measurements, 1977).
[36] “Clinical neutron dosimetry part I: determination of absorbed dose in a patient treated by external beams of fast neutrons,” Technical Report 45, (International Commission on Radiation Units and Measurements, 1989).
[37] P. Andreo et al., “Absorbed dose determination in external beam radiotherapy: an international code of practice for dosimetry based on standards of absorbed dose to water,” Technical Report Series No. 398, (International Atomic Energy Agency, 2000).
[38] “Recording, and reporting proton-beam therapy” Technical Report 78, (International Commission on Radiation Units and Measurements, 2008).
[39] C. P. Karger, O. Jäkel, H. Palmons, T. Kanai, “Dosimetry for ion beam radiotherapy,” Phys. Med. Biol., 55, 193-234, (2010).
[40] D. E. Alburger, D. Raparia, M. S. Zucher, “Phantoms with BF-3 detectors for boron neutron capture therapy applications,” Med. Phys., 25, 1735–1738, (1999).
[41] D. A. Tattam, D. A. Allen, T. D. Beynon, G. Constantine, S. Green, M. C. Scott, D. R. Weave, “In-phantom neutron fluence measurements in the orthogonal Birmingham boron neutron capture therapy beam,” Med. Phys., 25, 1964–1966, (1998).
[42] Y. D. Harker, R. A. Anderl, G. K. Becker, L. G. Miller, “Spectral characterization of the epithermal neutron beam at the Brookhaven medical research reactor,” Nucl. Sci. Eng., 110, 355–368, (1992).
[43] C. A. Perks, A. B. Gibson, “Neutron spectrometry and dosimetry for boron neutron capture therapy,” Radiat. Prot. Dosimetry 44, 425–428, (1992).
[44] A. F. Bielajew, Fundamentals of the Monte Carlo method for neutral and charged particle transport, (The University of Michigan, U.S.A., 2001).
[45] M. J. Berger, Monte Carlo calculation of the penetration and diffusion of fast charged particles, volume 1 of Methods in Computational Physics, (Academic Press, New York and London, 1963).
[46] P. Andreo, “Monte Carlo techniques in medical radiation physics,” Phys. Med. Biol., 36(7), 861, (1991).
[47] X-5 Monte Carlo Team, “MCNP- A General Monte Carlo N-Particle Transport Code, Version 5, Volume I: Overview and Theory,” Report LA-UR-03-1987 (Los Alamos National Laboratory, 2003).
[48] “Current status of neutron capture therapy,” IAEA-TECDOC-1223 Technical reports series, (International Atomic Energy Agency, 2001).
[49] THOR BNCT brochure, (available URL: http://bnct.web.nthu.edu.tw/files/14-1155-12744,r11-1.php, accessed in April, 2014).
[50] Y.-H. Liu, “Neutronic Characterization of an Epithermal Neutron Beam in Boron Neutron Capture Therapy,” Doctoral dissertation, (National Tsing Hua University, 2009).
[51] Y.-C. Lin, “Radiation Dose Rate Measurement in a Mixed Radiation Field Using Paired Ionization Chambers,” Doctoral dissertation (National Tsing Hua University, Taiwan, 2013).
[52] HIT brochure, (available URL: http://www.klinikum.uni heidelberg.de/Brochures.118199.0.html?&L=1, accessed in April 2014).
[53] M. Krämer et al., “Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization,” Phys. Med. Biol., 45, 3299–3317, (2000).
[54] J. Telsemeyer, “ Investigation of an Amorphous Silicon Flat-Panel Detector for Ion Radiography,” Doctoral disertation, (University of Heidelberg, 2012).
[55] K. Parodi et al., “Monte Carlo simulations to support start-up and treatment planning of scanned proton and carbon ion therapy at a synchrotron-based facility,”Phys. Med. Biol., 57:3759–3784, (2012).
[56] U. Weber and G. Kraft, “Design and construction of a ripple filter for a smoothed depth dose distribution in conformal particle therapy,” Phys. Med. Biol., 44, 2765–2775, (1999).
[57] W. L. McLaughlin, J. C. Humphreys, D. Hocken, and W. J. Chappas, “Radiochromic dosimetry for validation and commissioning of industrial radiation processes,” in Progress in Radiation Processing , Proceedings of the Sixth International Meeting, Ottawa, 1987, edited by F. M. Fraser, Radiat. Phys. Chem. 31, 505-514 (1988).
[58] W. L. McLaighlin, “Novel radiation dosimetry systems,” invited paper in High Dose Dosimetry for Radiation Processing, Proceedings of International Symposium, Vienna, 1990, STI/PUB/846 (International Atomic Energy Agency, Vienna, 1991), pp. 3-27.
[59] “Radiochromic Film Dosimetry”, Report No. 63, (American Association of Physicists in Medicine, 1998).
[60] M.-C. Hsiao and S.-H. Jiang, “A characterization study of Gafchromic EBT film as a two dimensional dosimeter,” Nucl. Tech., 168, 191-195, (2009).
[61] M.-C. Hsiao, “Measurements on The Penumbral Region of Multi-leaf Collimator in a Medical Linear Accelerator,” Diploma thesis, (National Tsing Hua University, 2007)
[62] S. Reinhardt, M. Hillbrand, J. J. Wilkens, W. Assmann, “Comparison of Gafchromic EBT2 and EBT3 films for clinical photon and proton beams,” Med. Phys., 39(8) 5257-5262, (2012).
[63] “GAFCHROMIC® EBT2: self-developing film for radiotherapy dosimetry,” (International Specialty Products, 2009).
[64] D. F. Lewis, Gafchromic Film, 2010 (available URL: http://online1.ispcorp.com/en-US/gafchromic/Pages/ProductDetail .aspx?BU=GafChromi&prdId=41046).
[65] P. Lindsay et al., “Investigation of energy dependence of EBT and EBT-2 Gafchromic film,” Med. Phys. 37(2), 571–576 (2010).
[66] J. G. H. Sutherland and D. W. O. Rogers, “Monte Carlo calculated absorbed-dose energy dependence of EBT and EBT2 film,” Med. Phys. 37(3), 1110–1116 (2010).
[67] B. Hartmann, “Quality Assurance in Ion Beam Therapy: Investigations towards New Detectors,” Diploma thesis, (Martin-Luther University Halle-Wittenberg, 2010).
[68] W.W. Bradshaw, D.G. Cadena, G.W. Crawford and H.A.W. Spetzler, “The use of alanine as a solid dosimeter,” Rad. Res., 17, 11–21 (1962).
[69] International Commission on Radiation Units and Measurements (ICRU), “Dosimetry systems for use in radiation processing” (ICRU Report 80), Journal of the ICRU 80 (2008).
[70] S. Onori, F. d’Errico, C. De Angelis, E. Egger, P. Fattibene, and I. Janovsky, “Alanine dosimetry of proton therapy beams,” Med. Phys., 24, 447 (1997).
[71] R. Herrmann, Jäkel O., H. Palmans, P. Sharpe, and N. Bassler, “Dose response of alanine detectors irradiated with carbon ion beams,” Med. Phys., 38, 1859–1866 (2011).
[72] A. Ableitinger, S. Vatnitsky, R. Herrmann, N. Bassler, H. Palmans, P. Sharpe, S. Ecker, N. Chaudhri, O. Jäkel, D. Georg, “Dosimetry auditing procedure with alanine dosimeters for light ion beam therapy: results of a pilot study,” Radiother. Oncol., 108, 99-106 (2013).
[73] H.M. Gerstenberb, J.W. Hansen, J.J. Coyne, and J. Zoetelief, „Calculation of the relative effectiveness of alanine for neutrons up to 17.1 MeV,” Rad. Prot. Dos., 31, 85–89 (1990).
[74] B. Ciesielski and L. Wielopolski, “The effects of boron on the electron paramagnetic resonance spectra of alanine irradiated with thermal neutrons,” Rad. Res., 144, 59–63 (1995).
[75] F. Trompier, P. Fattibene, D. Tikunov, A. Bartolotta, A. Carosi, and M.C. Doca, “EPR dosimetry in a mixed neutron and gamma radiation field,” Rad. Prot. Dos., 110, 437–442 (2004).
[76] “Photon, electron, proton, and neutron interaction data for body tissues” Technical Report 46, (International Commission on Radiation Units and Measurements, 1992).
[77] J.W. Hansen, and K.J. Olsen, “Theoretical and experimental radiation effectiveness of the free radical dosimeter alanine to irradiation with heavy charged particles,” Rad. Res. 104, 15–27 (1985).
[78] Y.-H. Liu, “清華水池式反應器硼中子捕獲治療設施之標準操作程序書: 超熱中子射束驗證與測量,” 2009.
[79] Los Alamos National Laboratory website (available URL: https://laws.lanl.gov/vhosts/mcnp.lanl.gov/index.shtml, accessed in March 2014).
[80] D. Pelowitz, “MCNPX User’s Manual,” Report LA-CP-11-00438 (Los Alamos National Laboratory, 2005).
[81] The NIST website (available URL: http://www.nist.gov/pml/data/, accessed in April 2014).
[82] L. Zhao and I. J. Das, “Gafchromic EBT film dosimetry in proton beams,” Phys. Med. Biol., 55, 291–301, (2010).
[83] B. Arjomandy, R. Tailor, L. Zhao and S. Devic, “EBT2 film as a depth-dose measurement tool for radiotherapy beams over a wide range of energies and modalities,” Med. Phys., 39, 912–21, (2012).
[84] B. Arjomandy et al., “Energy dependence and dose response of Gafchromic EBT2 film over a wide range of photon electron and proton beam energies,” Med. Phys., 37 1942–7 (2010).
[85] M. Martišíková and O. Jäkel, “Gafchromic EBT films for ion dosimetry,” Radiat. Meas., 45, 1268–1270, (2010a).
[86] M. Martišíková and O. Jäkel, “Dosimetric properties of Gafchromic EBT films in monoenergetic medical ion beams,” Phys. Med. Biol., 55 3741–3751, (2010b).
[87] M. Martišíková and O. Jäkel, “Dosimetric properties of Gafchromic EBT films in medical ion beams,” Phys. Med. Biol., 55 5557–5567, (2010c).
[88] J. J. Butts and R. Katz R, “Theory of RBE for heavy ion bombardment of dry enzymes and viruses,” Radiat. Res., 30, 855–871, (1967).
[89] J. W. Hanson and K. J. Olsen, “Experimental and calculated response of a radiochromic dye film dosimeter to high LET radiations,” Radiat. Res., 97, 1–15, (1984).
[90] AAPM, “Protocol for clinical reference dosimetry of high-energy photon and electron beams”, Task Group Report No. 51 (AAPM, 1999).
[91] M. J. Berger, J. S. Coursey, M. A. Zucker and J. Chang, “ESTAR, PSTAR, and ASTAR: computer programs for calculating stopping-power and range tables for electrons, protons, and helium ions (version 1.2.3),” (Gaithersburg, MD: National Institute of Standards and Technology) http://physics.nist.gov/Star, (2005).
[92] D. Kirby et al., “LET dependence of GafChromic films and an ion chamber in low-energy proton dosimetry Phys. Med. Biol., 55, 417–433, (2010).
[93] B. Hartmann, “Quality Assurance in Ion Beam Therapy: Investigations towards New Detectors,” Diploma thesis, (Martin-Luther University Halle-Wittenberg, 2010).
[94] G. Angellier, M. Gautier and J. Hérault, “Radichromic EBT2 dosimetry for low-energy proton therapy,” Med. Phys., 38, 6171–6177 (2011).
[95] D. Jette and W. Chen, “Creating a spread-out Bragg peak in proton beams,” Phys. Med. Biol., 56, 131-138 (2011).
[96] J.W. Hansen, K.J. Olsen, and M. Wille, “The alanine radiation detector for high and low LET dosimetry,” Rad. Prot. Dos. 19, 43-47 (1987).
[97] J.W. Hansen, and K.J. Olsen, “Predicting decay in free-radical concentration in L-α-alanine following high-LET radiation exposures”, Appl. Radiat. Isot. 40, 935–939 (1989).
[98] J.W. Hansen, and K.J. Olsen, “Theoretical and experimental radiation effectiveness of the free radical dosimeter alanine to irradiation with heavy charged particles,” Rad. Res. 104, 15–27 (1985).
[99] N. Bassler et al. “The antiproton depth-dose curve measured with alanine detectors,” Nucl. Instr. and Meth., B 266, 929-936 (2008).
[100] P.H.G. Sharpe, and J.P. Septhon, “Alanine dosimetry at NPL - the development of a mailed reference dosimetry service at radiotherapy dose levels,” Technical Report, IAEA-SM-356/65 (1999).
[101] Y.-H. Liu et al., “Performance evaluation of the source description of the THOR BNCT epithermal neutron beam,” Appl. Radiat. Isot., 69, 1892-1896, (2011).
[102] S. Onori, F. d’Errico, C. De Angelis, E. Egger, P. Fattibene, and I. Janovsky, “Alanine dosimetry of proton therapy beams,” Med. Phys., 24, 447 (1997). [103] R. Herrmann, Jäkel O., H. Palmans, P. Sharpe, and N. Bassler, “Dose response of alanine detectors irradiated with carbon ion beams,” Med. Phys., 38, 1859–1866 (2011).
[104] A. Ableitinger, S. Vatnitsky, R. Herrmann, N. Bassler, H. Palmans, P. Sharpe, S. Ecker, N. Chaudhri, O. Jäkel, D. Georg, “Dosimetry auditing procedure with alanine dosimeters for light ion beam therapy: results of a pilot study,” Radiother. Oncol., 108, 99-106 (2013).
[105] G. J. Kutcher, L. Coia, M. Gillin, W. F. Hanson, S. Leibel, R. J. Morton, J. R. Palta, J. A. Purdy, L. E. Reinstein, G. K. Svensson, M. Weller, L. Wingfield, “Comprehensive QA for radiation oncology: report of AAPM radiation therapy committee task group 40,” Med Phys 21(4): 581–618, (1994).
[106] E. E., Klein, J. Hanley, J. Bayouth, F.F. Yin, W. Simon, S. Dresser, C. Serago, F. Aguirre, L. Ma, B. Arjomandy, C. Liu, C. Sandin, T. Holmes, “Task Group 142 report: quality assurance of medical accelerators,” American Association of Physicists in Medicine. Med Phys 36(9): 4197–4212, (2009).
[107] I. Auterinen, T, Serén, P. Kotiluoto, J. Uusi-Simola, S. Savolainen, “Quality assurance procedures for the neutron beam monitors at the FiR 1 BNCT facility,” Appl Radiat Isot 61(5): 1015–1019, (2004).
[108] J. Rassow, F. Stecher-Rasmussen, W. Voorbraak, R. Moss, C. Vroegindeweij, K. Hideghéty, W. Sauerwien, “Comparison of quality assurance for performance and safety characteristics for boron neutron capture therapy in Petten/NL with medical electron accelerators,” Radiat Oncol 59:99–108, (2001).
[109] C. P. Raaijmakers, E. L. Nottelman, M. W. Konijnenberg, B. J. Mijnheer, “Dose monitoring for boron neutron capture therapy using a reactor-based epithermal neutron beam,” Phys Med Biol 41(12):2789–2797, (1996).
[110] Y.-H. Liu et al., “Quality control and quality assurance procedures at the THOR BNCT facility,” Appl. Radiat. Isotop., 69, 1897-1900, (2011).
|